In Novo Nordisk A/S’s home country of Denmark, the popularity of weight-loss drugs is fueling economic growth, but local ...

A once-weekly injection for weight loss known as a ‘GP-1 agonist’. It mimics a hormone in the gut that reduces our desire to eat and controls sugar in the blood. Developed originally for diabetes but ...

From legal pitfalls to temperature-sensitive drugs, here’s how to travel safely and legally with your medication ...

A little weight gain during the menopause is normal, but when it happens to a generation who came of age in the skinny-chic Nineties and beach-body-ready Noughties, the judgement is real. It is ...

It turns out that obesity may be much more complicated than we thought, with the condition potentially existing in up to 11 ...

On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...

The rise of GLP-1 drugs is a reminder that we must move beyond the simple equation of thinness as health and value. These ...

Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...

I suffer from nightmares that wake me up. I read that they can be caused by a dairy intolerance. Do you think this might be ...

Hims & Hers Health recurring revenue grew 111% YoY, boosted by personalization and chronic care. Forecasting $2.35B revenue ...

KATIE Price has revealed her son Harvey now weighs 30st, as she gave fans an update on him taking weight loss jabs. The ...

UnitedHealth Group's pharmacy benefits manager, OptumRx Inc., was hit with an Employee Retirement Income Security Act of 1974 ...